Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
clinical trials
fda
5
×
life sciences
national blog main
national top stories
new york top stories
novartis
zolgensma
5
×
biotech
boston blog main
boston top stories
gene therapy
national
new york blog main
san francisco top stories
biogen
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
seattle blog main
seattle top stories
spinal muscular atrophy
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
amgen
avexis
brian kaspar
centers for disease control and prevention
genentech
glaxosmithkline
What
roundup
bio
biotech
fda
news
past
therapy
according
age
akcea
america
approved
atrophy
august
bigger
biggest
biogen
busy
cases
centers
cigarettes
come
continues
control
convoluted
daily
days
deal
deaths
decisions
democrats
devices
disease
dreams
drug
drugs
electronic
emerging
evrysdi
friday
Language
unset
Current search:
zolgensma
×
fda
×
@xconomy.com
3 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@xconomy.com
4 years ago
Biotech Roundup: Vaping Toll Rises, NASH News, Akcea Shakeup & More
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com
4 years ago
Bio Roundup: Head and Spine Previews, Biogen Moves, IPO Dreams & More
@xconomy.com
5 years ago
With $100M MeiraGTx Deal, J&J Signals Bigger Move Into Gene Therapy
